Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Carol Goldman, DACM, L. OM
Dr. Carol A. Goldman is director of the herb department at the Won Institute of Graduate Studies, and in private practice in Narberth and Philadelphia, Pa. Learn more at CarolGoldmanAcupuncture.com.